 |
 |
Search
- Page Path
-
- HOME
- Search
- Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
- Juyeon Oh, Sung Yong Park, Sook Young Lee, Ju Yeol Song, Ga Yun Lee, Ji Hyun Park, Han Bum Joe
- Received June 3, 2022 Accepted July 31, 2022
-
DOI: https://doi.org/10.4097/kja.22331 [Epub ahead of print]
-
PDF
- Anesthesia for ovarian teratoma resection using remimazolam and remifentanil in a patient with anti-N-methyl-D-aspartate receptor encephalitis: two case reports
- Yoon Hyuk Hwang, YoungSuk Shon, Young Joon Yoon, Jong Hoon Yeom
- Received April 20, 2022 Accepted July 13, 2022
-
DOI: https://doi.org/10.4097/kja.22241 [Epub ahead of print]
-
PDF
- Remimazolam – current knowledge on a new intravenous benzodiazepine anesthetic agent
- Seong-Hyop Kim, Jörg Fechner
- Korean J Anesthesiol. 2022;75(4):307-315. Published online May 19, 2022
-
Full text 
PubReader 
ePub 
Crossref - TDM PDF PDF(Korean)
- Psychogenic coma after general anesthesia with remimazolam and remifentanil – a case report
- Song Hyun Kim, Kye Min Kim, Yun-Hee Lim, Byung Hoon Yoo, Joonho Cho, In-Jung Jun
- Received April 20, 2022 Accepted May 9, 2022
-
DOI: https://doi.org/10.4097/kja.22242 [Epub ahead of print]
-
PDF
- ARTICLE CATEGORY
- Editorial Office
-
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128 Fax: +82-2-792-4089 E-mail: journal@anesthesia.or.kr
Copyright © 2022 by Korean Society of Anesthesiologists.
